IMR Press / CEOG / Special Issues / hysteroscopic_adhesiolysis

Hysteroscopic Adhesiolysis

Submission deadline: 30 June 2024
Special Issue Editors
  • Xiaona Lin
    Obstetrics/Gynecology & Reproductive Center Sir Run Run Shaw Hospital Medical School, Zhejiang University, Hangzhou, China
    Interests: hysteroscopic adhesiolysis; preventing adhesion reformation; endometria injury; endometrium regeneration
  • Dongmei Song
    Hysteroscopy center, Fuxing Hospital, Capital Medical University, Beijing, China
    Interests: intrauterine adhesion; chronic endometritis; endometrial polyp
Special Issue Information

Dear Colleagues,

Hysteroscopic adhesiolysis is the main clinical treatment for uterine adhesions. The main purpose of surgery is to restore normal uterine shape, but recurrence is still a major problem after operation. Several comprehensive measures are often used to prevent the formation of re-adhesions and promote endometrial regeneration, including estrogen therapy and placement of a uterine barrier. However, the results are not good for patients with moderate and severe uterine adhesions, with the recurrence rate being as high as 62.5%. In recent years, animal experiments and a small number of clinical trials have shown that tissue engineering therapy with stem cells can accelerate the repair of damaged endometrium. However, regardless of the source of stem cells, the new endometrial cells do not have the necessary responsiveness to estrogen and progesterone required to achieve the periodic physiological changes of the endometrial surface.

Our team has spent many years conducting clinical research on the prevention and treatment of intrauterine adhesions. Over the past 10 years we have developed and performed comprehensive adhesion prevention and treatment methods, including sharp separation operative techniques, shortened review time, intrauterine balloon placement, G-CSF intrauterine perfusion, etc. Significant curative effects have been observed using these methods, with higher pregnancy and live birth rates than those reported in the literature. However, the recurrence rate for cases with moderate and severe intrauterine adhesions is still around 25-30%, and the postoperative live birth rate remains less than 60%. Effective prevention of intrauterine adhesions and the promotion of endometrial repair remain difficult problems in clinical practice.

Prof. Dr. Xiaona Lin and Dr. Dongmei Song
Guest Editors

Keywords
hysteroscopic adhesiolysis
operative techniques and outcome
endometrium regeneration
intrauterine adhesions
recurrence
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Back to top